Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuharu Ueda

Showing results (371-380 of 382) with videos related to

Pageof 39
Sort By:
Journal of Neurology|November 16, 2019
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
ESC Heart Failure|September 28, 2021
Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathyFumi Oike, Hiroki Usuku, Eiichiro Yamamoto, et al.
Journal of Neurology|February 8, 2020
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
Nature Microbiology|May 13, 2025
Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitmentKenji Sugata, Akhinur Rahman, Koki Niimura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 25, 2020
JCS 2020 Guideline on Diagnosis and Treatment of Cardiac AmyloidosisHiroaki Kitaoka, Chisato Izumi, Yasuhiro Izumiya, et al.
Journal of the American Heart Association|April 22, 2026
Right Atrial Function as a Novel Predictor for New-Onset Atrial Fibrillation in Transthyretin Amyloid CardiomyopathyNaoto Kuyama, Yasuhiro Izumiya, Seiji Takashio, et al.
Stroke and Vascular Neurology|April 18, 2025
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registryHirotaka Hayashi, Satoshi Namitome, Seigo Shindo, et al.
Scientific Reports|November 17, 2023
Transthyretin amyloid deposition in ligamentum flavum (LF) is significantly correlated with LF and epidural fat hypertrophy in patients with lumbar spinal stenosisKazuya Maeda, Kazuki Sugimoto, Masayoshi Tasaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 24, 2024
Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial FibrillationHirochika Yamasaki, Hidekazu Kondo, Tomoaki Shiroo, et al.
JACC. Asia|April 25, 2026
Patient Characteristics and Diagnosis of Transthyretin Amyloid Cardiomyopathy in Japan: Baseline Analysis of J-COSSAJin Endo, Kazumasa Tanzawa, Yasunori Sato, et al.
Pageof 39

Showing results (371-380 of 382) with videos related to

Sort By:
Pageof 39
Journal of Neurology|November 16, 2019
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
ESC Heart Failure|September 28, 2021
Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathyFumi Oike, Hiroki Usuku, Eiichiro Yamamoto, et al.
Journal of Neurology|February 8, 2020
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
Nature Microbiology|May 13, 2025
Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitmentKenji Sugata, Akhinur Rahman, Koki Niimura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 25, 2020
JCS 2020 Guideline on Diagnosis and Treatment of Cardiac AmyloidosisHiroaki Kitaoka, Chisato Izumi, Yasuhiro Izumiya, et al.
Journal of the American Heart Association|April 22, 2026
Right Atrial Function as a Novel Predictor for New-Onset Atrial Fibrillation in Transthyretin Amyloid CardiomyopathyNaoto Kuyama, Yasuhiro Izumiya, Seiji Takashio, et al.
Stroke and Vascular Neurology|April 18, 2025
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registryHirotaka Hayashi, Satoshi Namitome, Seigo Shindo, et al.
Scientific Reports|November 17, 2023
Transthyretin amyloid deposition in ligamentum flavum (LF) is significantly correlated with LF and epidural fat hypertrophy in patients with lumbar spinal stenosisKazuya Maeda, Kazuki Sugimoto, Masayoshi Tasaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 24, 2024
Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial FibrillationHirochika Yamasaki, Hidekazu Kondo, Tomoaki Shiroo, et al.
JACC. Asia|April 25, 2026
Patient Characteristics and Diagnosis of Transthyretin Amyloid Cardiomyopathy in Japan: Baseline Analysis of J-COSSAJin Endo, Kazumasa Tanzawa, Yasunori Sato, et al.
Pageof 39